Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Nsit Stock Analysis Insight Enterprises Inc Posts 1.61 Percent Gain Near 68 Dollar Price Point 20260401 1 Is Beamr Bmr Stock Declining Price At 1.42 Up 1.43 20260402 Is Range Rangr Stock Good For Short Term Price At 0.33 Up 10.96 20260406 Why Is Finwise Bancorp Finw Stock Underperforming The Market Price At 16.15 Up 0.62 20260408 Is Aeye Inc. Lidrw Stock A Safe Investment Price At 0.03 Down 1.64 20260406 Chegg CHGG Stock Is It Testing Key Levels Chegg Inc posts 907 EPS beat narrowerthanexpected loss The one question every Ashford Hosp AHT investor should ask Breakout Watch 20260507 Market Recap SP 500 gains as broad market rally lifts all major US indices MRK Merck and Company Inc posts Q4 2025 EPS beat but shares dip 2 percent amid muted investor sentiment Why Mint MIMI ability to execute stands out Bearish Sentiment 20260511 Exxon Mobil Corporation XOM TopTier Integrated Energy Play Positioned for Sustained Upside Amid Prolonged High Oil Price Cycle Is Psyence PBM stock a suitable buy candidate Soars 20260420 iShares Silver Trust SLV Positioned for Extended Upside Amid PostGeopolitical Precious Metals Recovery FUFU BitFuFu reports far wider than expected Q4 2025 loss even as shares edge slightly higher today What ExlService Holdings EXLS does that makes it resilient Institutional Demand 20260508 What BRC Group RILYT accounting reveals about the business BRC Group posts 171 per share loss with no analyst estimates PZG Paramount blows past Q1 2026 EPS estimates yet shares fall 8 percent in todays trading Ross Stores ROST Resilient OffPrice Retail Play Outperforming Peers Amid Broad Sector Weakness TREE LendingTree posts steep Q4 2025 EPS miss sending shares down 386 percent amid weak investor sentiment Arch Pref F ACGLO Q1 2026 Disappoints EPS 250 Below 253 Views TFI TFII Crushes Q1 2026 Estimates EPS 069 Tops Views Is ALX Oncology ALXO Undervalued at 204 20260515 WHO Declares Ebola Outbreak in DR Congo an International Health Emergency Market Implications Under Scrutiny Top 5 States Account for Nearly Half of Indias GDP as Regional Economic Divide Widens The Secretive Economics of Orchid Breeding A DecadeLong Gamble for High Returns Nvidias Cash Strategy Under Scrutiny Dividend Boost or Capital Allocation Shift Neurogene NGNE Stock Down 422 Support Test at 2845 20260515 Brag House Holdings TBH Q4 2025 Earnings Significant EPS Miss Amid Challenging Quarter Figure FIGR Steady at 3640 Awaiting Next Catalyst 20260520 Hope Bancorp Inc HOPE Q1 2026 Earnings Modest EPS Beat Amid Stable Banking Operations Cellebrite CLBT Reports Strong Q1 2026 Revenue NA EPS Beats Telsey Advisory Group Highlights Lowes Resilient Execution Amid Housing Market Headwinds China Urges APEC Cooperation as Minister Skips Opening Session Due to Urgent Official Business South Koreas KOSPI Reaches Record High as Asian Markets Eye USIran Talks Apples Record Stock Surge Faces Pivotal Test at Upcoming WWDC AI Showcase Oil Investors Wary as Potential Strait of Hormuz Transit Fees Loom Industry Data Chiefs Say ESI Q1 2026 Earnings EPS Surprise Beats Estimates Stock Rises Saia Q1 2026 Earnings EPS Edges Past Estimates as Stock Slips Slightly RAND Q1 2026 Earnings Reported EPS of 018 Stock Falls 313 Star Equity Holdings Inc STRR Q1 2026 Earnings Significant EPS Miss Amid Operational Challenges QCLS Q4 2017 Earnings Massive EPS Miss Fails to Deter Investors Nuveen Dynamic Municipal Opportunities Fund NDMO Creeps Higher Consolidating in a Narrow Range American Outdoor Brands AOUT Slides 125 as Stock Tests Key Support Levels Lyell Immunopharma LYEL Falls Sharply Key Support Levels in Focus After 69 Drop CRISPR Therapeutics Consolidates Near Support as Gene Editing Sector Awaits Catalysts Is Balchem BCPC stock trading at a premium Q4 2025 Earnings Fall Short Is SNDL Inc SNDL stock worth buying today Q4 2025 Profit Exceeds Views CenterPoint CNP Stock Is It Building a Base Q4 2025 Below Expectations Market Recap Technology leads broad gains as consumer sector lags mild upswing LRMR Larimar Therapeutics Q4 loss widens 41 miss as drug development costs climb shares edge lower